Association Of Liver Fatty Acid Binding Protein With Acute Kidney Injury In Paediatric Patients After Cardiac Surgery

Muhammad Basharat Khan1, Tahira Naseem2, Haseen Dil Wazir3

  • 1Department of pathology, Ayub medical college Abbottabad.

Insights

Urinary Liver fatty acid-binding protein (uL-FABP) can predict acute kidney injury (AKI) in children after heart surgery. Measuring uL-FABP levels at 4 hours offers early detection, aiding timely interventions to prevent AKI.

Area of Science:

  • Pediatric Cardiology
  • Nephrology
  • Biomarker Discovery

Background:

  • Acute kidney injury (AKI) is a frequent complication following cardiac surgery in children.
  • Urinary Liver fatty acid-binding protein (uL-FABP) shows promise as a biomarker for renal injury and recovery.
  • Early diagnosis of AKI is crucial for timely treatment and improved patient outcomes.

Purpose of the Study:

  • To evaluate uL-FABP as an early diagnostic biomarker for AKI in pediatric patients undergoing cardiac surgery.
  • To assess the potential of uL-FABP for monitoring renal status and guiding early therapeutic interventions.

Main Methods:

  • A descriptive study was conducted at Sheikh Zayed Hospital, Lahore, from 2015 to 2016.
  • Convenience sampling was used to select patients for analysis of blood and urine markers.
  • Levels of serum creatinine and urinary L-FABP (uL-FABP) were measured.

Main Results:

  • 11.4% of 88 patients developed AKI post-cardiac surgery.
  • Serum creatinine rose 24-48 hours post-surgery, while uL-FABP elevated at 4 hours.
  • An optimal uL-FABP cut-off of 269 ng/l demonstrated 80% sensitivity and 83.3% specificity for early AKI detection.

Conclusions:

  • uL-FABP is a potential early predictor of AKI in pediatric cardiac surgery patients.
  • Early detection of AKI using uL-FABP can facilitate prompt treatment strategies.
  • uL-FABP may serve as a valuable biomarker for renal health monitoring in this population.
Abstract

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
55
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
49
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
40
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
94
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
59